Loading...
AstraZeneca PLC
ZEG.DE•XETRA
HealthcareDrug Manufacturers - General
€127.95
€0.80(0.63%)
AstraZeneca PLC (ZEG.DE) Financial Performance & Statements
Review AstraZeneca PLC’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
18.03%
↑ 18.03%
Operating Income Growth
22.09%
↑ 22.09%
Net Income Growth
18.14%
↑ 18.14%
Operating Cash Flow Growth
14.65%
↑ 14.65%
Operating Margin
19.21%
↑ 19.21%
Gross Margin
81.39%
↑ 81.39%
Net Profit Margin
14.14%
↑ 14.14%
ROE
19.18%
↑ 19.18%
ROIC
13.69%
↑ 13.69%
AstraZeneca PLC (ZEG.DE) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for AstraZeneca PLC stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $14.89B | $13.56B | $12.94B | $12.68B |
| Cost of Revenue | $2.73B | $3.08B | $2.18B | $2.22B |
| Gross Profit | $12.17B | $10.48B | $10.76B | $10.46B |
| Gross Profit Ratio | $0.82 | $0.77 | $0.83 | $0.83 |
| R&D Expenses | $4.68B | $3.12B | $3.008B | $2.78B |
| SG&A Expenses | $5.55B | $5.29B | $5.06B | $4.63B |
| Operating Expenses | $10.13B | $8.38B | $8.009B | $7.35B |
| Total Costs & Expenses | $12.86B | $11.46B | $10.19B | $9.56B |
| Interest Income | $64.00M | $183.00M | $100.00M | $111.00M |
| Interest Expense | $429.00M | $457.00M | $443.00M | $413.00M |
| Depreciation & Amortization | $2.34B | $1.82B | $1.28B | $1.25B |
| EBITDA | $4.43B | $4.10B | $4.12B | $4.57B |
| EBITDA Ratio | $0.30 | $0.30 | $0.32 | $0.36 |
| Operating Income | $2.04B | $2.11B | $2.75B | $3.12B |
| Operating Income Ratio | $0.14 | $0.16 | $0.21 | $0.25 |
| Other Income/Expenses (Net) | -$370.00M | -$278.00M | -$349.00M | -$315.00M |
| Income Before Tax | $1.67B | $1.83B | $2.40B | $2.80B |
| Income Before Tax Ratio | $0.11 | $0.13 | $0.19 | $0.22 |
| Income Tax Expense | $166.00M | $395.00M | $469.00M | $620.00M |
| Net Income | $1.50B | $1.43B | $1.93B | $2.18B |
| Net Income Ratio | $0.10 | $0.11 | $0.15 | $0.17 |
| EPS | $0.97 | $0.92 | $1.24 | $1.41 |
| Diluted EPS | $0.96 | $0.92 | $1.24 | $1.40 |
| Weighted Avg Shares Outstanding | $1.55B | $1.55B | $1.55B | $1.55B |
| Weighted Avg Shares Outstanding (Diluted) | $1.56B | $1.56B | $1.56B | $1.56B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan